论文部分内容阅读
目的 :观察孕期及产后甲亢临床特点 ,对其治疗进行分析。方法 :所有甲亢患者均用酶标法检测FT3 、FT4、TSH ,应用PTU治疗。结果 :本文报道了 2 2例孕期甲亢 :4例分别在孕早、中期终止妊娠 ;18例应用抗甲亢药物正常分娩 ;4例产后甲亢 :3例为一过性 ,考虑为产后一过性甲状腺毒血症 ;1例为持续性甲状腺毒血症。孕产妇无甲亢危象发生。结论 :甲亢孕妇危险性升高 ,抗甲状腺药物治疗为首选 ,产后甲亢有一过性及持续性 ,治疗上需慎重
Objective: To observe the clinical features of post-natal hyperthyroidism and its treatment. Methods: All patients with hyperthyroidism were detected by enzyme-labeled FT3, FT4, TSH, the application of PTU treatment. Results: Twenty-two cases of hyperthyroidism in pregnancy were reported in this study. Four of them were terminated in early pregnancy and mid-term, respectively. Eighteen patients were given normal delivery of anti-hyperthyroidism drugs. Four postpartum hyperthyroidism patients were transient and considered as transient postnatal thyroid gland 1 case of persistent thyrotoxicosis. Pregnancy without hyperthyroidism crisis occurred. Conclusion: The risk of hyperthyroidism in pregnant women increased, anti-thyroid drug treatment is preferred, postpartum hyperthyroidism has a transient and persistent treatment should be careful